跳至主要内容
临床试验/NCT00651586
NCT00651586已完成2 期

Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers

Allergan0 个研究点目标入组 129 人开始时间: 2003年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
Allergan
入组人数
129
主要终点
Complete re-epithelialization of the corneal ulcer

研究概览

简要总结

This study evaluates the safety and efficacy of gatifloxacin 0.3% ophthalmic solution compared with ciprofloxacin 0.3% ophthalmic solution in patients with acute bacterial corneal ulcers

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
8 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis in one eye only of an acute bacterial corneal ulcer (>1mm)

排除标准

  • Corneal ulcer that in the opinion of the investigator had to be treated with fortified antibiotics, or multiple antibiotics, or anti-infectives other than study medication

研究组 & 干预措施

1

Experimental

Gatifloxacin 0.3% ophthalmic solution

干预措施: Gatifloxacin 0.3% ophthalmic solution (Drug)

2

Active Comparator

Ciprofloxacin 0.3% ophthalmic solution

干预措施: Ciprofloxacin 0.3% ophthalmic solution (Drug)

结局指标

主要结局

Complete re-epithelialization of the corneal ulcer

时间窗: Day 21

次要结局

  • Microbiological Cure(Day 21)
  • Patient reported outcomes(Day 21)
  • Investigator's evaluation of clinical efficacy(Day 21)

研究者

发起方
Allergan
申办方类型
Industry

相似试验